Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep353 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Relationship between pregnancy induced hypertension in women with gestational diabetes mellitus and proinflamatory cytokines

Lara-Barea Almudena , Sánchez-Lechuga Begoña , Vidal-Suárez Alvaro , Campos-Caro Antonio , Aguilar-Diosdado Manuel , López-Tinoco Cristina

Justification and objectives: Gestational Diabetes Mellitus (GDM) is associated with an increased risk of Pregnancy-Induced Hypertension (PIH). Previous studies suggest a relationship between inflammatory markers and the development of PIH and obstetric and perinatal complications. The aim of the study was to establish the relationship between pro and anti-inflammatory cytokines and the development of PIH and the impact on obstetric and perinatal outcomes.<p clas...

ea0070oc3.2 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Influence of obesity in the miRNome landscape: miR-4454, a tissue-specific regulator of insulin response

Sáez-Martínez Prudencio , Herrero-Aguayo Vicente , Jiménez-Vacas Juan M , López-Cánovas Juan L , Garrido-Sánchez Lourdes , Macías-González Manuel , López-Miranda José , Gómez--Gómez Enrique , Castaño-Fuentes Justo P , Gahete-Ortíz Manuel D , Luque-Huertas Raúl M

Obesity is a major health problem commonly associated with severe comorbidities, including insulin resistance and type 2 diabetes mellitus (T2DM). Emerging evidence suggests that production and secretion of certain micro RNAs (miRNAs) are dysregulated under adverse metabolic conditions and might exert a key role in the development and progression of different metabolic-related pathologies. However, the alteration of the plasma miRNA profile under obesity condition and its path...

ea0070yi6 | Young Investigators | ECE2020

Dysregulation of splicing factor 3B SUBUNIT 1 (SF3B1) is associated with the pathological transformation of the liver: Pharmacological inhibition with pladienolide-B as novel therapeutic tool in liver disease

Jiménez Vacas1 Juan Manuel , López-Cánovas Juan L , Del Rio-Moreno Mercedes , García-Fernandez Helena , Sánchez-Frias Marina E , Amado Victor , L-López Fernando , Fondevila Marcos F , Ciria Ruben , Briceño Javier , Nogueiras Rubén , De la Mata Manuel , Castaño Justo P , Rodriguez-Perálvarez Manuel , Luque Raúl M , Gahete Manuel D

Development and progression of liver diseases, from non-alcoholic fatty liver disease (NAFLD) to steatohepatitis (NASH), and hepatocellular carcinoma (HCC), seem to be accompanied by a dysregulation of the expression of alternative splicing variants (SVs) and appearance of aberrant SVs. The splicing factor 3B subunit 1 (SF3B1) represents a crucial player for the functional assembly of the spliceosome, the core machinery that controls the splicing process, and its activity can ...